*By clicking Next, I agree to receive emails from The JAX – NYSCF Collaborative.
The 2026 JAX-NYSCF Conference, September 23-24, brings together global leaders in translational stem cell science to drive insights, collaborations, and discoveries.
A ribbon-tying ceremony in Manhattan marks the debut of a unified platform integrating genetics, stem cell science, and AI to accelerate research and improve patient outcomes.
Read the Fall 2025 issue of Search Magazine. The Jackson Laboratory & The New York Stem Cell Foundation: A powerful alliance to accelerate the pace of discovery
The New York Stem Cell Foundation combines the depth of a highly focused disease research institute with the breadth of a wide-ranging philanthropic organization. Since our establishment in 2005, NYSCF has invested over $450 million in stem cell science and continues to conduct world-leading stem cell research, both in our own laboratory in New York City, and also in collaboration with major medical research and leading academic institutions around the world. NYSCF conducts and supports research in Alzheimer’s, Parkinson’s, multiple sclerosis, age-related macular degeneration, diabetes, cancer, psychiatric diseases, rare diseases, and more.
The NYSCF Research Institute, an independent disease research facility, is a non-profit accelerator that serves to bridge the gap between research institutions and pharmaceutical and biotech companies by reducing the cost, time, and risk that historically inhibit the development of new treatments and cures. NYSCF does this through our groundbreaking stem cell automation platform that integrates the most cutting-edge technologies, including artificial intelligence and robotics.
In October 2025, NYSCF was acquired by The Jackson Laboratory.
